The Glioblastoma Market is dynamic, characterized by evolving treatment paradigms and a robust pipeline of novel therapeutic candidates. Several key trends are shaping its present and will continue to influence its future trajectory. The glioblastoma market is estimated to be valued at USD 1.30 Bn in 2025 and is expected to reach USD 3.12 Bn by 2032, growing at a compound annual growth rate...